Timothy O’Leary.

Timothy O’Leary

Professor of information engineering and neuroscience
University of Cambridge

Timothy O’Leary is professor of information engineering and neuroscience at the University of Cambridge. His research lies at the intersection between physiology, computation and control engineering. His goal is to understand how nervous systems self-organize, adapt and fail, and to connect these to diversity and variability in nervous system properties.

Originally trained as a pure mathematician, O’Leary dropped out of a Ph.D. on hyperbolic geometry to study the brain. After retraining as an experimental physiologist, he obtained his doctorate in experimental and computational neuroscience from the University of Edinburgh in 2009.

He has worked as both an experimentalist and theoretician, on systems that span the scale from single ion channel dynamics to whole brain and behavior, and across invertebrate and vertebrate species. His group works closely with experimentalists to study neuromodulation, neural dynamics and how sensorimotor information is represented in the brain, more recently focusing on how neural representations evolve over time. He approaches these problems from an unusual perspective, citing engineering principles as being key to understanding the brain—and biology more widely.

From this contributor

Explore more from The Transmitter

Hand holding a vial of microplastics.

Measuring plastic in the brain: Improving, but incomplete

Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.

By Amber Dance
18 September 2026 | 9 min read
Calendar with deadline.

Incredible shrinking grant deadlines at the BRAIN Initiative

“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.

By Brendan Borrell
17 September 2026 | 4 min read

Sylvia Fogel, reshaping U.S. autism research strategy

In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.

By Brady Huggett
17 September 2026 | 2 min read